Jacobs Levy Equity Management, Inc Tarsus Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$11.57 - $19.63 $482,087 - $817,923
41,667 New
41,667 $752,000
Q3 2022

Nov 15, 2022
BUY
$14.08 - $18.5 $69,076 - $90,761
4,906 Added 5.98%
86,948 $1.49 Million
Q2 2022

Aug 15, 2022
BUY
$11.08 - $19.08 $909,025 - $1.57 Million
82,042 New
82,042 $1.2 Million

Others Institutions Holding TARS

# of Institutions
170
Shares Held
43.3M
Call Options Held
484K
Put Options Held
4.1K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.4B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email